Showing 6,009 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Bad science & bogus treatments

'No cure' for HIV in Zimbabwe says UN, following claims from local preacher

Editor's pick
UN News
1 November 2018
Injectable & long-acting PrEP

Beyond Truvada – what is the future of PrEP?

News
31 October 2018
Starting treatment

Bictegravir matches dolutegravir in first-line treatment

News
31 October 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
Treatment simplification strategies

Two-drug protease inhibitor treatment as effective as three-drug treatment – and fewer stop due to side-effects

News
30 October 2018
New & experimental HIV treatments

First large HIV prevention trial using antibodies will probably not be the last

News
29 October 2018
The search for a cure

The Miami monkey cured with two antibodies

News
26 October 2018
Injectable & long-acting PrEP

The long tail of injectable PrEP is especially long for women

News
25 October 2018
Adherence

How substance use affects adherence to PrEP among gay and bisexual men

Editor's pick
Medical Xpress
24 October 2018
Child developmental issues

Dolutegravir Use During Pregnancy: What Are the Risks?

Editor's pick
Infectious Disease Advisor
22 October 2018
Health monitoring in resource-limited settings

Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds

News
22 October 2018
New & experimental HIV treatments

ViiV Seeks FDA Approval for Two-Drug HIV Treatment

Editor's pick
Poz
22 October 2018
The search for a cure

Gilead and Aelix join forces to pursue HIV 'cure'

Editor's pick
PMLiVE
18 October 2018
Treatment simplification strategies

Studies confirm long-term effectiveness of new single-tablet regimens

News
18 October 2018
Starting treatment

Rapid Initiation of HIV Care: Assessing Safety and Efficacy

Editor's pick
Infectious Disease Advisor
16 October 2018
Injectable & long-acting HIV treatment

Wide range of views about switching to weekly, monthly or biannual ART

News
15 October 2018
Child developmental issues

Efavirenz, but not dolutegravir, linked to neurological problems in children

News
11 October 2018
New & experimental HIV treatments

Long-acting injectable implant shows promise for HIV treatment and prevention

Editor's pick
University of North Carolina
9 October 2018
New & experimental HIV treatments

Doravirine combination works well as a switch option

News
8 October 2018
New & experimental HIV treatments

Dual-antibody combination therapy produces three to seven months of viral suppression without pills

News
8 October 2018
Changing treatment

Merck’s HIV Therapy DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate) Meets Primary Efficacy Endpoint in Phase 3 DRIVE-SHIFT Study Evaluating Switch to DELSTRIGO from Other Antiretroviral Treatment Regimens

Editor's pick
Merck press release
5 October 2018
Changing treatment

Janssen Reports Switching to SYMTUZA™ Results in Maintained High Virologic Suppression and No Resistance Development up to 96-Weeks in Virologically Suppressed Adults with HIV-1

Editor's pick
Janssen press release
5 October 2018
Child developmental issues

Efavirenz in HIV-positive pregnant women, risk of neurological condition in children

Editor's pick
IDSA press release
5 October 2018
The search for a cure

Vedolizumab could be used to target latent HIV harboring in gut

Editor's pick
Healio
4 October 2018